Oridonin Loaded Solid Lipid Nanoparticles Enhanced Antitumor Activity in MCF-7 Cells

Figure 1

Particle size distribution of ORI-loaded SLNs determined by dynamic light scattering (DLS) (a) and transmission electron microscopy (TEM) (b). Drug release profiles of free ORI and ORI-loaded SLNs in vitro (c).

(a)

(b)

(c)